Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mikhak Zamaneh | Chief Medical Officer | 6 | $42.3K | $0 | 2024-07-03 |
| COLEMAN KIRK ALLEN | Chief Financial Officer | 30 | $34.3K | $636.0K | 2024-07-03 |
| Weisman Harlan F | President and CEO | 14 | $410.0K | $0 | 2024-07-03 |
| Lee Catherine Chai-zon | Director | 4 | $0 | $0 | 2024-07-03 |
| Roberts Brandi | Director | 6 | $5.0K | $0 | 2024-07-03 |
| KING THOMAS BRAXTON | Director | 4 | $0 | $0 | 2024-07-03 |
| MILLS ROBERT S | Director | 24 | $35.0K | $1.68M | 2024-07-03 |
| ROCAMBOLI STEPHEN | Director | 22 | $29.0K | $907.0K | 2024-07-03 |
| Patane Michael A | Director | 2 | $0 | $0 | 2024-04-18 |
| Carlson Clint Duane | 10% Owner | 2 | $0 | $95.0K | 2023-08-16 |
| Fletcher Aaron G.L. | Director | 19 | $4.40M | $0 | 2022-12-29 |
| THURMAN RANDY H | Director | 12 | $34.9K | $807.5K | 2022-09-29 |
| Mattes Glenn R. | President and CEO | 26 | $297.5K | $4.37M | 2022-05-16 |
| CANO CHRISTOPHER | Chief Operating Officer | 1 | $0 | $0 | 2021-09-22 |
| Fairbairn Malcolm | Director | 5 | $89.5K | $1.20M | 2021-05-19 |
| Lung Therapeutics, Inc. | 10% Owner | 4 | $0 | $24.56M | 2021-03-26 |
| WINDSOR JAMES BRIAN | Chief Science Officer | 7 | $25.0K | $395.0K | 2020-12-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KING THOMAS BRAXTON | Director | A Award deriv | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 3,165 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | A Award deriv | 2024-07-03 | 2024-07-08 | 10,184 | — | $0 | 10,184 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | A Award deriv | 2024-07-03 | 2024-07-08 | 10,184 | — | $0 | 10,184 | SEC↗ |
| Roberts Brandi | Director | A Award deriv | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 3,165 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 3,165 | SEC↗ |
| Lee Catherine Chai-zon | Director | A Award deriv | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| Weisman Harlan F | President and CEO | A Award deriv | 2024-07-03 | 2024-07-08 | 27,480 | — | $0 | 27,480 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 39,165 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | A Award | 2024-07-03 | 2024-07-08 | 10,184 | — | $0 | 145,184 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | A Award | 2024-07-03 | 2024-07-08 | 10,184 | — | $0 | 45,859 | SEC↗ |
| Roberts Brandi | Director | A Award | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 23,165 | SEC↗ |
| MILLS ROBERT S | Director | A Award | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 59,145 | SEC↗ |
| Lee Catherine Chai-zon | Director | A Award | 2024-07-03 | 2024-07-08 | 1,583 | — | $0 | 1,583 | SEC↗ |
| Weisman Harlan F | President and CEO | A Award | 2024-07-03 | 2024-07-08 | 27,480 | — | $0 | 842,095 | SEC↗ |
| Weisman Harlan F | President and CEO | A Award deriv | 2024-04-18 | 2024-04-22 | 44,967 | — | $0 | 44,967 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 4,667 | — | $0 | 4,667 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| Roberts Brandi | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 5,333 | — | $0 | 5,333 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 4,667 | — | $0 | 4,667 | SEC↗ |
| Lee Catherine Chai-zon | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 3,556 | — | $0 | 3,556 | SEC↗ |
| Patane Michael A | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 3,556 | — | $0 | 3,556 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award deriv | 2024-04-18 | 2024-04-22 | 3,110 | — | $0 | 3,110 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award deriv | 2023-12-13 | 2023-12-15 | 132,442 | — | $0 | 132,442 | SEC↗ |
| Lee Catherine Chai-zon | Director | A Award deriv | 2023-12-01 | 2023-12-04 | 132,442 | — | $0 | 132,442 | SEC↗ |
| Patane Michael A | Director | A Award deriv | 2023-12-01 | 2023-12-04 | 132,442 | — | $0 | 132,442 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2023-12-01 | 2023-12-04 | 52,858 | — | $0 | 52,858 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2023-12-01 | 2023-12-04 | 52,858 | — | $0 | 52,858 | SEC↗ |
| Roberts Brandi | Director | A Award deriv | 2023-12-01 | 2023-12-04 | 52,858 | — | $0 | 52,858 | SEC↗ |
| Carlson Clint Duane | 10% Owner | S Sale | 2023-08-16 | 2023-08-17 | 1,000 | $0.39 | $390 | 5,064,000 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | P Buy | 2023-08-15 | 2023-08-15 | 120,000 | $0.25 | $30.0K | 135,000 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | P Buy | 2023-08-15 | 2023-08-15 | 20,000 | $0.25 | $5.0K | 35,675 | SEC↗ |
| MILLS ROBERT S | Director | P Buy | 2023-08-15 | 2023-08-15 | 40,000 | $0.25 | $10.0K | 55,980 | SEC↗ |
| Roberts Brandi | Director | P Buy | 2023-08-15 | 2023-08-15 | 20,000 | $0.25 | $5.0K | 20,000 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | P Buy | 2023-08-15 | 2023-08-15 | 20,000 | $0.25 | $5.0K | 36,000 | SEC↗ |
| Weisman Harlan F | President and CEO | P Buy | 2023-08-15 | 2023-08-15 | 600,000 | $0.25 | $150.0K | 814,615 | SEC↗ |
| Carlson Clint Duane | 10% Owner | S Sale | 2023-08-15 | 2023-08-17 | 215,000 | $0.44 | $94.6K | 5,065,000 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | A Award deriv | 2023-03-22 | 2023-03-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mikhak Zamaneh | Chief Medical Officer | P Buy | 2023-03-10 | 2023-03-13 | 15,000 | $0.82 | $12.3K | 15,000 | SEC↗ |
| Weisman Harlan F | President and CEO | P Buy | 2023-03-10 | 2023-03-13 | 150,000 | $0.88 | $132.0K | 214,615 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | P Buy | 2023-03-10 | 2023-03-13 | 12,000 | $0.79 | $9.5K | 15,675 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | P Buy | 2023-03-10 | 2023-03-13 | 13,000 | $0.80 | $10.4K | 16,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2022-12-29 | 2022-12-30 | 33,475 | — | $0 | 33,475 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2022-12-29 | 2022-12-30 | 33,475 | — | $0 | 33,475 | SEC↗ |
| Roberts Brandi | Director | A Award deriv | 2022-12-29 | 2022-12-30 | 20,968 | — | $0 | 20,968 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2022-12-29 | 2022-12-30 | 33,475 | — | $0 | 33,475 | SEC↗ |
| Weisman Harlan F | President and CEO | P Buy | 2022-12-15 | 2022-12-19 | 50,000 | $1.06 | $53.0K | 64,615 | SEC↗ |
| Weisman Harlan F | President and CEO | A Award deriv | 2022-12-03 | 2022-12-06 | 1,792,450 | — | $0 | 1,792,450 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy deriv | 2022-11-22 | 2022-11-23 | 21,735 | — | $0 | 21,735 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-11-22 | 2022-11-23 | 43,470 | $1.15 | $50.0K | 143,470 | SEC↗ |
| THURMAN RANDY H | Director | M Exercise deriv | 2022-09-29 | 2022-09-30 | 40,255 | — | $0 | 84,670 | SEC↗ |
| THURMAN RANDY H | Director | S Sale | 2022-09-29 | 2022-09-30 | 40,255 | $4.29 | $172.7K | 0 | SEC↗ |
| THURMAN RANDY H | Director | M Exercise | 2022-09-29 | 2022-09-30 | 40,255 | $2.50 | $100.6K | 40,255 | SEC↗ |
| Weisman Harlan F | Director | P Buy | 2022-05-20 | 2022-05-20 | 4,615 | $5.50 | $25.4K | 14,615 | SEC↗ |
| Weisman Harlan F | Director | P Buy | 2022-05-18 | 2022-05-20 | 2,500 | $5.12 | $12.8K | 10,000 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | P Buy | 2022-05-17 | 2022-05-17 | 425 | $4.83 | $2.1K | 3,675 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-05-17 | 2022-05-17 | 24,600 | $5.08 | $125.0K | 109,600 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | P Buy | 2022-05-16 | 2022-05-17 | 3,000 | $4.54 | $13.6K | 18,722 | SEC↗ |
| Mattes Glenn R. | President and CEO | P Buy | 2022-05-16 | 2022-05-17 | 16,000 | $4.78 | $76.5K | 36,000 | SEC↗ |
| COLEMAN KIRK ALLEN | Chief Financial Officer | P Buy | 2022-05-16 | 2022-05-17 | 1,250 | $4.40 | $5.5K | 3,250 | SEC↗ |
| Weisman Harlan F | Director | P Buy | 2022-05-16 | 2022-05-17 | 2,500 | $4.74 | $11.8K | 7,500 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-05-16 | 2022-05-17 | 85,000 | $4.86 | $413.1K | 85,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-04-04 | 2022-04-04 | 500,000 | $6.43 | $3.21M | 500,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-04-04 | 2022-04-04 | 42,000 | $6.89 | $289.4K | 542,000 | SEC↗ |
| CANO CHRISTOPHER | Chief Operating Officer | A Award deriv | 2021-09-22 | 2021-09-24 | 43,000 | — | $0 | 200,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | P Buy | 2021-09-16 | 2021-09-16 | 1,000 | $7.30 | $7.3K | 2,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | P Buy | 2021-09-16 | 2021-09-16 | 10,000 | $7.10 | $71.0K | 20,000 | SEC↗ |
| Fairbairn Malcolm | Director | P Buy | 2021-05-19 | 2021-05-19 | 10,000 | $8.95 | $89.5K | 10,000 | SEC↗ |
| THURMAN RANDY H | Director | P Buy | 2021-05-18 | 2021-05-19 | 1,050 | $9.40 | $9.9K | 1,050 | SEC↗ |
| Lung Therapeutics, Inc. | 10% Owner | S Sale | 2021-03-26 | 2021-03-30 | 715,000 | $14.00 | $10.01M | 2,235,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise deriv | 2021-03-15 | 2021-03-17 | 5,000 | — | $0 | 277,883 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise deriv | 2021-03-15 | 2021-03-17 | 50,000 | — | $0 | 944,227 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise deriv | 2021-03-15 | 2021-03-17 | 5,250 | — | $0 | 102,423 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise deriv | 2021-03-15 | 2021-03-17 | 14,756 | — | $0 | 107,673 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | S Sale | 2021-03-15 | 2021-03-17 | 5,000 | $17.05 | $85.3K | 1,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise | 2021-03-15 | 2021-03-17 | 5,000 | $2.50 | $12.5K | 6,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2021-03-15 | 2021-03-17 | 50,000 | $17.04 | $852.0K | 10,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise | 2021-03-15 | 2021-03-17 | 50,000 | $2.50 | $125.0K | 60,000 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise | 2021-03-15 | 2021-03-17 | 5,250 | $5.00 | $26.3K | 35,728 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise | 2021-03-15 | 2021-03-17 | 14,756 | $2.50 | $36.9K | 30,478 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | S Sale | 2021-03-15 | 2021-03-17 | 20,006 | $16.85 | $337.1K | 15,722 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise deriv | 2021-02-16 | 2021-02-18 | 5,000 | — | $0 | 282,883 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise deriv | 2021-02-16 | 2021-02-18 | 40,000 | — | $0 | 994,227 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | S Sale | 2021-02-16 | 2021-02-18 | 5,000 | $16.82 | $84.1K | 1,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise | 2021-02-16 | 2021-02-18 | 5,000 | $2.50 | $12.5K | 6,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise | 2021-02-16 | 2021-02-18 | 40,000 | $2.50 | $100.0K | 50,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2021-02-16 | 2021-02-18 | 40,000 | $16.82 | $672.8K | 10,000 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise deriv | 2021-02-10 | 2021-02-12 | 700 | — | $0 | 151,319 | SEC↗ |
| MILLS ROBERT S | Director | S Sale | 2021-02-10 | 2021-02-12 | 700 | $20.16 | $14.1K | 15,980 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise | 2021-02-10 | 2021-02-12 | 700 | $2.50 | $1.8K | 16,680 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise deriv | 2021-01-20 | 2021-01-20 | 12,600 | — | $0 | 152,019 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise | 2021-01-20 | 2021-01-20 | 12,600 | $2.50 | $31.5K | 28,580 | SEC↗ |
| MILLS ROBERT S | Director | S Sale | 2021-01-20 | 2021-01-20 | 12,600 | $20.20 | $254.5K | 15,980 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise deriv | 2021-01-19 | 2021-01-20 | 55,100 | — | $0 | 164,619 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise | 2021-01-19 | 2021-01-20 | 55,100 | $2.50 | $137.8K | 71,080 | SEC↗ |
| MILLS ROBERT S | Director | S Sale | 2021-01-19 | 2021-01-20 | 55,100 | $19.56 | $1.08M | 15,980 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise deriv | 2021-01-15 | 2021-01-20 | 5,000 | — | $0 | 287,883 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise deriv | 2021-01-15 | 2021-01-20 | 40,000 | — | $0 | 1,034,227 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise | 2021-01-15 | 2021-01-20 | 5,000 | $2.50 | $12.5K | 6,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | S Sale | 2021-01-15 | 2021-01-20 | 5,000 | $17.50 | $87.5K | 1,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise | 2021-01-15 | 2021-01-20 | 40,000 | $2.50 | $100.0K | 50,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2021-01-15 | 2021-01-20 | 40,000 | $17.51 | $700.4K | 10,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise deriv | 2020-12-23 | 2020-12-29 | 10,000 | — | $0 | 292,883 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise deriv | 2020-12-23 | 2020-12-29 | 30,000 | — | $0 | 1,074,227 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | M Exercise | 2020-12-23 | 2020-12-29 | 10,000 | $2.50 | $25.0K | 11,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | S Sale | 2020-12-23 | 2020-12-29 | 10,000 | $15.24 | $152.4K | 1,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2020-12-23 | 2020-12-29 | 30,000 | $15.33 | $459.9K | 10,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise | 2020-12-23 | 2020-12-29 | 30,000 | $2.50 | $75.0K | 40,000 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise deriv | 2020-12-11 | 2020-12-15 | 22,794 | — | $0 | 219,719 | SEC↗ |
| MILLS ROBERT S | Director | S Sale | 2020-12-11 | 2020-12-15 | 22,794 | $14.58 | $332.3K | 15,980 | SEC↗ |
| MILLS ROBERT S | Director | M Exercise | 2020-12-11 | 2020-12-15 | 22,794 | $2.50 | $57.0K | 38,774 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | M Exercise deriv | 2020-12-07 | 2020-12-09 | 25,000 | — | $0 | 134,429 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | M Exercise | 2020-12-07 | 2020-12-09 | 25,000 | $2.50 | $62.5K | 30,000 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | S Sale | 2020-12-07 | 2020-12-09 | 25,000 | $15.80 | $395.0K | 5,000 | SEC↗ |
| Lung Therapeutics, Inc. | 10% Owner | S Sale | 2020-12-04 | 2020-12-08 | 250,000 | $13.86 | $3.46M | 2,950,000 | SEC↗ |
| Lung Therapeutics, Inc. | 10% Owner | S Sale | 2020-12-04 | 2020-12-08 | 300,000 | $13.86 | $4.16M | 3,200,000 | SEC↗ |
| Lung Therapeutics, Inc. | 10% Owner | S Sale | 2020-12-04 | 2020-12-08 | 500,000 | $13.85 | $6.92M | 3,500,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-11-24 | 2020-11-24 | 5,000 | $15.13 | $75.7K | 100,000 | SEC↗ |
| THURMAN RANDY H | Director | S Sale | 2020-11-13 | 2020-11-13 | 5,000 | $17.17 | $85.9K | 0 | SEC↗ |
| Fairbairn Malcolm | Director | S Sale | 2020-11-12 | 2020-11-13 | 11,669 | $15.97 | $186.4K | 0 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise deriv | 2020-11-11 | 2020-11-13 | 15,722 | — | $0 | 122,429 | SEC↗ |
| THURMAN RANDY H | Director | M Exercise deriv | 2020-11-11 | 2020-11-13 | 34,504 | — | $0 | 124,925 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | S Sale | 2020-11-11 | 2020-11-13 | 15,722 | $15.76 | $247.8K | 0 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise | 2020-11-11 | 2020-11-13 | 15,722 | $2.50 | $39.3K | 15,722 | SEC↗ |
| THURMAN RANDY H | Director | M Exercise | 2020-11-11 | 2020-11-13 | 34,504 | $2.50 | $86.3K | 39,504 | SEC↗ |
| THURMAN RANDY H | Director | S Sale | 2020-11-11 | 2020-11-13 | 34,504 | $15.91 | $549.0K | 5,000 | SEC↗ |
| Fairbairn Malcolm | Director | S Sale | 2020-11-11 | 2020-11-13 | 63,331 | $15.93 | $1.01M | 11,669 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise deriv | 2020-11-10 | 2020-11-13 | 108,830 | — | $0 | 1,104,227 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | M Exercise deriv | 2020-11-10 | 2020-11-13 | 15,000 | — | $0 | 302,883 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise deriv | 2020-11-10 | 2020-11-13 | 21,278 | — | $0 | 138,151 | SEC↗ |
| Mattes Glenn R. | President and CEO | M Exercise | 2020-11-10 | 2020-11-13 | 108,830 | $2.50 | $272.1K | 118,830 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2020-11-10 | 2020-11-13 | 108,830 | $15.00 | $1.63M | 10,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | M Exercise | 2020-11-10 | 2020-11-13 | 15,000 | $2.50 | $37.5K | 16,000 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | S Sale | 2020-11-10 | 2020-11-13 | 15,000 | $15.12 | $226.8K | 1,000 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | M Exercise | 2020-11-10 | 2020-11-13 | 21,278 | $2.50 | $53.2K | 21,278 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | S Sale | 2020-11-10 | 2020-11-13 | 21,278 | $15.14 | $322.1K | 0 | SEC↗ |
| Mattes Glenn R. | President and CEO | S Sale | 2020-09-25 | 2021-01-20 | 3,000 | $17.00 | $51.0K | 7,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| Mattes Glenn R. | President and CEO | A Award deriv | 2020-08-24 | 2020-08-26 | 152,000 | — | $0 | 1,213,057 | SEC↗ |
| Weisman Harlan F | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | A Award deriv | 2020-08-24 | 2020-08-26 | 40,000 | — | $0 | 317,883 | SEC↗ |
| Fairbairn Malcolm | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 13,200 | — | $0 | 105,455 | SEC↗ |
| THURMAN RANDY H | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 30,300 | — | $0 | 242,512 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-05-26 | 2020-05-26 | 20,000 | $5.08 | $101.6K | 95,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-04-15 | 2020-04-17 | 5,581 | $4.72 | $26.3K | 75,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-04-06 | 2020-04-06 | 6,252 | $4.24 | $26.5K | 69,419 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-04-03 | 2020-04-06 | 16,748 | $3.97 | $66.5K | 63,167 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-04-02 | 2020-04-06 | 500 | $3.75 | $1.9K | 46,419 | SEC↗ |
| Fairbairn Malcolm | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 92,255 | — | $0 | 92,255 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | A Award deriv | 2019-12-20 | 2019-12-26 | 50,000 | — | $0 | 277,883 | SEC↗ |
| Mattes Glenn R. | President and CEO | A Award deriv | 2019-11-29 | 2020-08-26 | 89,952 | — | $0 | 1,061,057 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2019-11-29 | 2020-08-26 | 25,838 | — | $0 | 212,212 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | A Award deriv | 2019-11-29 | 2019-12-03 | 5,920 | — | $0 | 227,883 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| Mattes Glenn R. | President and CEO | A Award deriv | 2019-11-29 | 2019-12-03 | 25,214 | — | $0 | 971,105 | SEC↗ |
| MILLS ROBERT S | Director | A Award deriv | 2019-11-29 | 2019-12-03 | 2,351 | — | $0 | 186,374 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| THURMAN RANDY H | Director | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| Weisman Harlan F | Director | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | A Award deriv | 2019-10-29 | 2019-10-29 | 71,963 | — | $0 | 221,963 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 179,693 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion deriv | 2019-10-29 | 2019-10-29 | 43,919 | — | $0 | 135,806 | SEC↗ |
| Mattes Glenn R. | President and CEO | A Award deriv | 2019-10-29 | 2019-10-29 | 332,868 | — | $0 | 945,891 | SEC↗ |
| MILLS ROBERT S | Director | C Conversion deriv | 2019-10-29 | 2019-10-29 | 10,980 | — | $0 | 184,023 | SEC↗ |
| THURMAN RANDY H | Director | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 135,806 | SEC↗ |
| Weisman Harlan F | Director | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 135,806 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 135,806 | SEC↗ |
| ROCAMBOLI STEPHEN | Director | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 135,806 | SEC↗ |
| Mattes Glenn R. | President and CEO | A Award deriv | 2019-10-29 | 2019-10-30 | 332,868 | — | $0 | 945,891 | SEC↗ |
| Fletcher Aaron G.L. | Director | C Conversion | 2019-10-29 | 2019-10-29 | 43,919 | — | $0 | 45,919 | SEC↗ |
| MILLS ROBERT S | Director | C Conversion | 2019-10-29 | 2019-10-29 | 10,980 | — | $0 | 15,980 | SEC↗ |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasure | P Buy | 2019-10-25 | 2019-10-29 | 1,000 | $5.00 | $5.0K | 1,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2019-10-25 | 2019-10-29 | 2,000 | $5.00 | $10.0K | 2,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | P Buy | 2019-10-25 | 2019-10-29 | 10,000 | $5.00 | $50.0K | 10,000 | SEC↗ |
| MILLS ROBERT S | Director | P Buy | 2019-10-25 | 2019-10-29 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| THURMAN RANDY H | Director | P Buy | 2019-10-25 | 2019-10-29 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| Weisman Harlan F | Director | P Buy | 2019-10-25 | 2019-10-29 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| WINDSOR JAMES BRIAN | Chief Science Officer | P Buy | 2019-10-25 | 2019-10-29 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | P Buy | 2019-10-25 | 2019-10-30 | 10,000 | $5.00 | $50.0K | 10,000 | SEC↗ |
| Mattes Glenn R. | President and CEO | P Buy | 2019-10-25 | 2019-10-30 | 10,000 | $5.00 | $50.0K | 10,000 | SEC↗ |